ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,806 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentBaselImmunovant Sciences GmbH
Immunovant Sciences GmbH Logo
Verified· 2 sources

Immunovant Sciences GmbH

Summary

About the company

Immunovant Sciences GmbH is a clinical-stage immunology company developing anti‑FcRn therapies, including IMVT‑1402 and batoclimab, to reduce pathogenic IgG autoantibodies in autoimmune diseases. The product candidates are described as fully human monoclonal antibodies intended for subcutaneous administration with dosing that may be tailored to disease stage and severity.

AI-generated
Offering

Products & services

Industry:Research & Development
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
Pharmaceutical Industry
✓ Offered3
Development of anti-FcRn therapies
Development of anti-neonatal Fc receptor approaches to promote IgG catabolism in autoimmune diseases; focused on an investigational therapy with Imeroprubart (IMVT-1402).
Clinical development in autoimmune diseases
Clinical studies in the therapeutic areas of Graves’ Disease, Myasthenia Gravis, CIDP, Rheumatoid Arthritis, Sjögren’s Disease and Cutaneous Lupus Erythematosus.
Patient and study information
Information on autoimmune diseases, therapeutic areas and clinical trial participation; including overviews of Graves’ Disease, MG, CIDP, Sjögren’s Disease and CLE.

Knowledge

No knowledge articles yet

Once Immunovant Sciences GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Immunovant Sciences GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Immunovant Sciences GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Immunovant Sciences GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Viaduktstrasse 8
4051 Basel

At a glance

Legal form
Limited Liability Company
UID
CHE-297.527.393
Founded
2018 · 8 years
Last commercial register change
July 15, 2026
Employees
11 to 20

Similar companies

VE
Verein Energie Zukunft Schweiz
Basel
ST
Synendos Therapeutics AG
Basel
TT
TargImmune Therapeutics AG
Basel
VT
Vaderis Therapeutics AG
Basel